The potential mechanisms of action include direct inhibition of endothelial cell proliferation, decrease of vascular endothelial growth factor production by tumour cells, and increased activity of the tissue inhibitor of matrix metalloproteinase (TIMP). This evidence concerns the gene TIMP1 and neoplasm.